Thrombotic microangiopathies
Related Experiment Video
Updated: Sep 30, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Daniel Halevy1, Jai Radhakrishnan, Glen Markowitz
1Division of Nephrology, Department of Medicine, Columbia-Presbyterian Medical Center, New York, NY, USA.
Abstract:
The thrombotic microangiopathies (TMA) are a group of diseases associated with microangiopathic hemolytic anemia, thrombocytopenia, and end-organ dysfunction. These seemingly disparate entities share in common a pathogenic mechanism involving endothelial injury and thrombus formation. Prognosis and treatment depend on the nature of the underlying disease.
Related Concept Videos
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Transient Ischemic Attack l: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

